{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:13:01Z","timestamp":1784099581225,"version":"3.55.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Lymphovascular invasion (LVI) is a prognostic and treatment-driving parameter for low-stage, low-grade endometrial endometrioid adenocarcinoma (EEAC). There is lack of organizational recommendations\/guideline consensus regarding the clinically significant cutoff and pathologist agreement on cutoff thresholds has not been extensively studied. Digitized unannotated tumor-containing slides from 52 low-grade\/uterine corpus-confined EEAC of no specific molecular profile (NSMP) and mismatch repair-deficient (MMRd) molecular subgroups were reviewed by 6 gynecologic pathologists. The reviewers, blinded to the originally reported LVI status, independently evaluated for the presence of LVI and the maximum number of involved vessels in a single slide or slides, per case. To quantify inter-rater reliability, intraclass correlation coefficient (ICC) estimates and their 95% confidence intervals were calculated (ICC&lt;0.5=poor, 0.5 to 0.75=moderate, and 0.75 to 0.9=good and &gt;0.9=excellent). A total of 280 slides were evaluated. The overall inter-rater reliability for the presence of LVI was moderate (ICC=0.53) and was slightly higher in the MMRd (ICC=0.56) compared with NSMP (ICC=0.52) group. For specific quantification of LVI, the overall inter-rater reliability was also moderate (ICC=0.71) and higher in the MMRd (ICC=0.76) compared with NSMP (ICC=0.69) group. Perfect agreement (6\/6 reviewers with same assessment) only occurred for designations of no LVI or \u22655 involved vessels. There was a moderate level of inter-rater reliability that was not significantly affected by shifting the cutoff of involved vessels (from 3 to 4 to 5). Since a specific cutoff has no apparent bearing on the most reproducible cutoff for pathologists, future efforts should be directed towards obtaining clinical consensus for reporting purposes.<\/jats:p>","DOI":"10.1097\/pas.0000000000002563","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:00:30Z","timestamp":1778486430000},"page":"964-971","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gynecologic Pathologist Agreement on Presence and Quantification of Lymphovascular Invasion in Low-stage, Low-grade Endometrial Endometrioid Adenocarcinoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Darrell","family":"Martin","sequence":"first","affiliation":[{"name":"Laboratory Medicine Program, University Health Network, Toronto, ON, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakinah","family":"Thiryayi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"Laboratory Medicine and Genetics Program, Trillium Health Partners, Mississauga, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Grondin","sequence":"additional","affiliation":[{"name":"Department of Pathology, CHU de Qu\u00e9bec-Universit\u00e9 Laval, Quebec City, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pakbaz","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoosh","family":"Keyhanian","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The Ottawa Hospital\/University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodington","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Program, University Health Network, Toronto, ON, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kinloch","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-2000","authenticated-orcid":false,"given":"Anjelica","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Program, University Health Network, Toronto, ON, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"R1-20260715","doi-asserted-by":"crossref","first-page":"1286221","DOI":"10.3389\/fonc.2023.1286221","article-title":"Evaluation of prognostic significance of lymphovascular space invasion in early stage endometrial cancer: a systematic review and meta-analysis","volume":"13","author":"Qin","year":"2024","journal-title":"Front Oncol"},{"key":"R2-20260715","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00404-025-07997-6","article-title":"Evolution of lymphovascular space invasion in early-stage endometrial carcinoma: stratification, quantification, and clinical implications: a systematic review","volume":"312","author":"Sun","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"R4-20260715","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20260715","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"key":"R6-20260715","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"suppl 1","key":"R8-20260715","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/PGP.0000000000000524","article-title":"Pathologic prognostic factors in endometrial carcinoma (other than tumor type and grade)","volume":"38","author":"Singh","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20260715","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/his.15272","article-title":"Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma","volume":"86","author":"Peters","year":"2025","journal-title":"Histopathology"},{"key":"R11-20260715","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/his.13871","article-title":"Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer","volume":"75","author":"Peters","year":"2019","journal-title":"Histopathology"},{"key":"R12-20260715","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"R13-20260715","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PGP.0000000000000806","article-title":"Defining substantial lymphovascular space invasion in endometrial cancer","volume":"41","author":"Peters","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20260715","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"R15-20260715","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1136\/ijgc-2023-004606","article-title":"Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer","volume":"33","author":"Siegenthaler","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R16-20260715","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.brachy.2020.12.006","article-title":"Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer","volume":"20","author":"Barnes","year":"2021","journal-title":"Brachytherapy"},{"key":"R17-20260715","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"58","author":"St\u00e5lberg","year":"2019","journal-title":"Acta Oncol"},{"key":"R18-20260715","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/ijgc-2024-005746","article-title":"Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study","volume":"34","author":"Dagher","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"R19-20260715","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2020.07.024","article-title":"Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study","volume":"159","author":"Pifer","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R20-20260715","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/PGP.0000000000000710","article-title":"POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting","volume":"40","author":"Casey","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20260715","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djab029","article-title":"Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer","volume":"113","author":"Post","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"R22-20260715","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2025.04.589","article-title":"Molecular subgroup-specific prognostic value of semiquantitative lymphovascular space invasion in early-stage endometrioid endometrial cancer","volume":"197","author":"Loukovaara","year":"2025","journal-title":"Gynecol Oncol"},{"key":"R23-20260715","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12957-024-03483-6","article-title":"Prognostic significance of lymphovascular space invasion in early-stage low-grade endometrioid endometrial cancer: a fifteen-year retrospective Chinese cohort study","volume":"22","author":"Sun","year":"2024","journal-title":"World J Surg Oncol"},{"key":"R24-20260715","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40001-023-01084-9","article-title":"The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer","volume":"28","author":"Yarandi","year":"2023","journal-title":"Eur J Med Res"},{"key":"R25-20260715","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41379-019-0205-0","article-title":"Whole slide imaging equivalency and efficiency study: experience at a large academic center","volume":"32","author":"Hanna","year":"2019","journal-title":"Mod Pathol"},{"key":"R26-20260715","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/his.15329","article-title":"Importance of the criteria used for assessment of lymphovascular space invasion in endometrial carcinoma","volume":"86","author":"Huvila","year":"2025","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:00:40Z","timestamp":1784098840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002563","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"2025-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}